Ritlecitinib is under clinical development by Pfizer and currently in Phase II for Keloids. According to GlobalData, Phase II drugs for Keloids does not have sufficient historical data to build an ...

Keloids are fibrotic scars that extend beyond the boundaries of the original wound, often causing physical disfigurement and emotional distress. These scars are driven by an overproduction of ...

The United States leads the North American scar treatment market, holding a significant share in 2024. Projected to grow at a ...

While liquid nitrogen cryotherapy is effective, easy, and quick to administer, its application can cause a considerable amount of discomfort. This pain is frequently biphasic, with an immediate ...

POINT, Hanover — Young girls often receive monetary gifts during their bat mitzvah, but 12-year-old Kaila Tiner from New Jersey chose to give instead. She donated US$1,500 — most of it raised ...